PainChek®is pleased to announce it has extended its Australian partnership agreement with Montreal-based home health care software provider AlayaCare that will allow PainChek to enter the Canadian homecare market.
AlayaCare is a provider of revolutionary cloud-based home health care software which serves 500 global clients. Ithas an end-to-end solution spanning clinical documentation, back office functionality, client and family portals, remote patient monitoring, and mobile care worker functionality. It is focused on innovation and delivering home care of the future.
The Canadian market presents another sizeable market opportunity for PainChek, having grown to over $5 billion1 in annual operating revenue for home support services and home health care services as the population both ages and veers away from long term care facilities. It is estimated that 1 million2. Canadians are receiving care in a home or community-based setting, while there’s an estimated 500,000 Canadians living with dementia.
AlayaCare VP of Strategy and Corporate Development Neil Grunberg said:
“We’re delighted to be able to bring PainChek’s best-in-class, unique pain assessment tool to our clients in Canada, adding to the relationship we’ve established in the Australian market. PainChek is another high-quality, better outcomes feature for our cloud-based home health software solution that spans clinical, scheduling, billing, advanced reporting and more.”
PainChek® CEO Philip Daffas said:
“We’ve had an excellent working relationship with AlayaCare in the Australian market for both the residential aged care and homecare sectors, and we are eager to take this to the Canadian homecare market. This is an exciting and complementary business model for PainChek, allowing us to work with AlayaCare’s clients to assess the need for the PainChek offering and be able to contract and implement it remotely. It is a cost-effective, rapid and flexible business model built for modern day healthcare.”
In this initial phase, AlayaCare will provide lead generation and marketing support to PainChek in the Canadian market, while PainChek remains responsible for direct sales, implementation, training and technical support to the Canadian client base. AlayaCare will receive fees from PainChek for integration of the PainChek technology into the home care software platform in line with the Australian market agreement.
Active selling to clients in the Canadian market will commence upon regulatory clearance of PainChek from Health Canada, expected prior to the end of 2020.
1 https://www150.statcan.gc.ca/n1/daily-quotidien/190731/dq190731c-eng.htm
2 https://www150.statcan.gc.ca/n1/pub/82-003-x/2018009/article/00001-eng.htm
